Researchers evaluated 19 studies to explore the roles and perceptions of oncology nurse navigators, finding 4 primary themes. Researchers identified 3 groups of patients based on anxiety and sleep disturbance profiles. Patients with ibrutinib dose reductions after AEs had longer treatments and similar outcomes to those without reductions. Patients with CLL who relapsed after HSCT and then received venetoclax achieved outcomes consistent with trial data. The rituximab, fludarabine, and cyclophosphamide regimen appeared to be most effective for overall survival and response. Data suggest patients with CLL are more anxious when receiving intravenous versus oral treatment. Intensive salvage therapy had a 54% complete remission rate whereas non-intensive salvage therapy was lower at 18%. Milagros Elia, MA, APRN, ANP-BC, discusses the tragic fires in Maui and the massive impact these events have on cancer care. The study used only single-agent tacrolimus for GVHD prophylaxis. Rusfertide improved response maintenance and reduced the need for therapeutic phlebotomy. The trial cohort achieved a staggering 100% overall response rate after 7 days of treatment. The improvements occurred after haploidentical donor-matched transplant with PTCy and cord blood transplant. Despite prior reports of an association between the conditions, a recent database review found no direct connection. Studies show that expertise is growing in Western countries for the difficult endoscopic surgery. Young Black women experience breast cancer at higher rates than their White peers. Here's how you can find out your risks. Health care providers should be ready with recommendations on improving these 4 sexual well-being concerns. The effect of music interventions on anxiety is unclear, but most studies showed an improvement on pain and fatigue. Enteral probiotics and prebiotics, along with vitamin D supplementation, may help prevent gut GVHD in AHSCT patients. The treatment reduced the risk of aGVHD and cGVHD but did not improve non-relapse mortality or overall survival. While other symptoms did emerge, the most common was worry. Could improving other symptoms lessen worry?